Company Pulmonx Corporation

Equities

LUNG

US7458481014

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Ratings for Pulmonx Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Equipment

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
9.38 ^USD	+21.50%		+28.49%	-26.43%

May. 01	Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M	MT
May. 01	Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024

Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. The StratX Platform is a cloud-based quantitative CT analysis service that offers physicians with a report that is designed for its solution, which includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation and has been validated in multiple randomized controlled clinical trials.

Number of employees: 279

USD in Million	2022	Weight	2023	Weight	Delta
Interventional Pulmonology 100.0 %	54	100.0 %	69	100.0 %	+27.98%

USD in Million	2022	Weight	2023	Weight	Delta
United States 66.9 %	32	60.5 %	46	66.9 %	+41.34%
Europe, Middle-East and Africa 20.2 %	8	15.8 %	14	20.2 %	+62.95%
Germany 8.0 %	6	11.0 %	5	8.0 %	-6.93%
Asia Pacific 4.4 %	3	5.3 %	3	4.4 %	+5.48%
Other International 0.6 %	0	0.3 %	0	0.6 %	+157.42%

Managers	Title	Age	Since
Ryan Olivera CTO	Chief Tech/Sci/R&D Officer	-	-
Sri Radhakrishnan CTO	Chief Tech/Sci/R&D Officer	-	07-12-31
Lauren Cristina ADM	Chief Administrative Officer	-	08-12-31
Narinder S. Shargill CTO	Chief Tech/Sci/R&D Officer	-	-
Glendon French BRD	Director/Board Member	62	14-12-17
Sarah Huber SAM	Sales & Marketing	-	-
Geoffrey Rose PRN	Corporate Officer/Principal	50	19-12-31
John McKune AUD	Comptroller/Controller/Auditor	-	20-07-31
Lisa Paul HRO	Human Resources Officer	60	-
Marcee M. Maroney SAM	Sales & Marketing	54	-

Members of the board	Title	Age	Since
Richard Ferrari BRD	Director/Board Member	70	07-01-31
Glendon French BRD	Director/Board Member	62	14-12-17
Dana Mead CHM	Chairman	64	10-01-31
Daniel Florin BRD	Director/Board Member	60	19-12-31
Thomas Burns BRD	Director/Board Member	63	20-08-31
Georgia Garinois-Melenikiotou BRD	Director/Board Member	63	20-08-31
Alissa Lynch BRD	Director/Board Member	55	21-07-28
Tiffany Sullivan BRD	Director/Board Member	49	21-07-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	38,516,383	36,997,911 ( 96.06 %)	0	96.06 %

Name	Equities	%	Valuation
PRIMECAP Management Co. 14.65 %	5,646,451	14.65 %	52 M $
Fidelity Management & Research Co. LLC 8.588 %	3,309,501	8.588 %	31 M $
BlackRock Advisors LLC 7.726 %	2,977,555	7.726 %	28 M $
Morgan Stanley Investment Management, Inc. 5.913 %	2,278,721	5.913 %	21 M $
Vanguard Fiduciary Trust Co. 5.362 %	2,066,442	5.362 %	19 M $
Point72 Asset Management LP 4.764 %	1,836,083	4.764 %	17 M $
Point72 Asset Management LP 4.012 %	1,546,089	4.012 %	14 M $
Divisadero Street Capital Management LP 3.651 %	1,406,993	3.651 %	13 M $
Glendon French 2.898 %	1,116,758	2.898 %	10 M $
Kleiner Perkins Caufield & Byers LLC 2.582 %	994,971	2.582 %	9 M $

Pulmonx Corp.

700 Chesapeake Drive

94063, Redwood City

+650 364 0400

http://www.pulmonx.com

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.38 USD

Average target price

15.4 USD

Spread / Average Target

+64.18%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Equipment

	1st Jan change	Capi.
PULMONX CORPORATION	-26.43%	364M
SHOCKWAVE MEDICAL, INC.	+73.17%	12.38B
PENUMBRA, INC.	-18.08%	7.99B
MASIMO CORPORATION	+16.24%	7.21B
GETINGE AB	+3.34%	5.79B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+11.77%	5.35B
APT MEDICAL INC.	+29.65%	4.63B
ASAHI INTECC CO., LTD.	-17.74%	4.17B
INARI MEDICAL, INC.	-35.34%	2.44B
SKAN GROUP AG	+3.47%	2.03B

Medical Equipment